![]() |
|
|
Vol. 286, Issue 1, 382-391, July 1998
Department of Pharmacology, University of Tennessee School of
Medicine, Memphis, Tennessee 38163 (S.L.P., T.S., W.R.C.), and
Department of Microbiology, University of Memphis, Memphis, Tennessee
38152 (M.S.P.)
Binding of a Y1-subtype-selective agonist of neuropeptide Y
(NPY) receptor, (Leu31,Pro34)human peptide YY
(LP-PYY), to particulates from four rat brain areas (parietal cortex
area 1, piriform cortex, anterior hypothalamus and hippocampus) showed
a distinct response to LP-PYY and PYY, a uniformly low sensitivity to
ligands selective for the Y2, Y4 and
Y5 NPY receptor subtypes and high sensitivity to a
Y1 site-selective antagonist, BIBP-3226. The Y1
binding was sensitive to guanine nucleotide-binding protein (G protein)
agonist and antagonist nucleotides, with the rank order of guanosine
5'-O-(thiotriphosphate) (GTP
S) > GTP > GDP > guanosine
5'-O-(thiodiphosphate). However, guanine nucleotides did not affect
about one third of the specific Y1 binding. Most of
Y1 binding could be inhibited by a G protein nucleotide
site/docking site receptor mimic, mastoparan analog MAS-7. In all areas
examined, the Y1 binding of LP-PYY was little affected by
up to 100 µM of the antagonists of K+, Na+
and Ca++ channels, protein kinase C, phospholipase
A2, phospholipase D and phosphatidylinositol 3-kinase,
phospholipase substrate phospholipids, steroids or detergents. However,
the binding was potently inhibited by phospholipase C inhibitors
(especially the aminosteroid U-73122), which also dissociated the bound
Y1 ligand in steady-state conditions. U-73122 also
displaced the Y1 binding insensitive to GTP
S. Ligand association with the brain Y1 NPY receptor thus strongly
depends on activity of both G proteins and phospholipase C, implying
specific interactions of these transducers/effectors with the receptor molecule in ligand binding. A portion of brain Y1 sites
could be directly coupled to phospholipase(s) C.